ARTICLE | Clinical News
Immune Response regulatory update
May 16, 1994 7:00 AM UTC
The Carlsbad, Calif., company received Australian Patent No. 648,753 covering compositions and methods to prevent or treat autoimmune diseases. IMNR is conducting two Phase I trials of rheumatoid arth...